Market Overview:
The global cell-based assay market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for cell-based assays from research and academic institutes, pharma and biotech companies, and CROs. Additionally, the growing focus on personalized medicine is also contributing to the growth of this market. The kits and reagents segment is expected to dominate the global cell-based assay market in terms of revenue during the forecast period. This segment accounted for a share of more than 60% of the total revenue generated by this market in 2017. The high demand for kits and reagents from research institutes is driving the growth of this segment. In terms of application, research & academic institutes are expected to account for a major share of the global cell-based assay market during the forecast period.
Product Definition:
Cell based assays are a type of assay used to measure the activity or effectiveness of a drug, protein or other molecule. They involve culturing cells in a laboratory setting and then exposing them to the molecule being tested. The cells are then monitored for signs of activity, such as changes in gene expression or cell growth. Cell based assays can provide information about how well a molecule interacts with cells and can be used to screen potential new drugs.
Kits and Reagents:
Kits and reagents are the basic requirements for most of the modern day biological research. The growth factor in cell-based assays market is driven by factors such as growing demand for personalized medicine, increasing prevalence of chronic diseases, rising geriatric population base coupled with an increase in government funding to facilitate R&D activities related to biotechnology.
Synthesis Services:
Synthesis services are a set of chemical procedures used to make chemicals and compounds, which cannot be obtained through conventional raw materials or production processes. Synthesis is also known as chemical synthesis, chemical engineering, or just synthesis. It is the most general type of reaction process that combines two steps: preparation of starting material ( precursor ) and formation of desired product ( end product ). In between these two steps there may be many intermediate forms which are later converted to end products.
Application Insights:
Research & academic institutes held the largest share of the application segment in 2017. This is attributed to presence of a large number of research and academic institutions across the globe. Cell-based assays provide an easy and accurate way for researchers to test new drugs or therapies in vitro before conducting clinical trials. Thus, increasing demand from research and academic institutes is expected to drive growth over the forecast period.
Pharma & biotech companies are anticipated to be one of fastest growing segments during future years owing to rising R&D activities undertaken by various pharmaceutical companies for testing novel drug molecules using cell based assay techniques as a part-of-process screening method prior entering into costly animal models or human clinical trials phase. For instance, several novel drug molecules are being tested against cancer cells using protein interaction networks generated through bioinformatics analysis followed by automated cell line selection strategy performed on these data sets obtained from genomics studies conducted at different levels (molecular, cellular).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of CROs that offer services for molecular biology, cell and tissue culture, bioprocessing, and other related areas. Moreover, increasing investments by pharmaceutical companies for drug discovery will boost growth in this region.
In March 2016; Gilead Sciences Inc., one of the largest developers of HIV drugs received USD X billion from investors for its new project-to-manage (PCM) strategy which is expected to accelerate progress toward a cure for hepatitis B virus (HBV). The company has also invested around USD X million till date on this project.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in cell-based assay platforms
- Growing number of CRO and CMO services providers
- Rising investment in life sciences sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Based Assays Market Research Report
By Type
Kits and Reagents, Synthesis Services
By Application
Research & Academic Institutes, Pharma & Biotech Companies, CROs
By Companies
Thermo Fisher Scientific, Agilent, Merck KGaA, Qiagen, Bio-Rad, Promega, Funakoshi Co., Ltd., BioVendor, Canopy Biosciences, Genecopoeia, GenoSensor, Takara Bio, Zymo Research, Biocat, LC Sciences, NanoString Technologies, Quanta BioSciences, Phalanx Biotech, FUJIFILM Wako Pure Chemical Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Cell Based Assays Market Report Segments:
The global Cell Based Assays market is segmented on the basis of:
Types
Kits and Reagents, Synthesis Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research & Academic Institutes, Pharma & Biotech Companies, CROs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Agilent
- Merck KGaA
- Qiagen
- Bio-Rad
- Promega
- Funakoshi Co., Ltd.
- BioVendor
- Canopy Biosciences
- Genecopoeia
- GenoSensor
- Takara Bio
- Zymo Research
- Biocat
- LC Sciences
- NanoString Technologies
- Quanta BioSciences
- Phalanx Biotech
- FUJIFILM Wako Pure Chemical Corporation
Highlights of The Cell Based Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kits and Reagents
- Synthesis Services
- By Application:
- Research & Academic Institutes
- Pharma & Biotech Companies
- CROs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Based Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell-based assays are a type of assay that uses cells to measure the presence or absence of a particular molecule. Cells can be isolated from biological samples and then used to test for the presence or absence of a specific molecule.
Some of the major players in the cell based assays market are Thermo Fisher Scientific, Agilent, Merck KGaA, Qiagen, Bio-Rad, Promega, Funakoshi Co., Ltd., BioVendor, Canopy Biosciences, Genecopoeia, GenoSensor, Takara Bio, Zymo Research, Biocat, LC Sciences, NanoString Technologies, Quanta BioSciences, Phalanx Biotech, FUJIFILM Wako Pure Chemical Corporation.
The cell based assays market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Based Assays Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Based Assays Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Based Assays Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Based Assays Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Based Assays Market Size & Forecast, 2018-2028
4.5.1 Cell Based Assays Market Size and Y-o-Y Growth
4.5.2 Cell Based Assays Market Absolute $ Opportunity
Chapter 5 Global Cell Based Assays Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cell Based Assays Market Size Forecast by Type
5.2.1 Kits and Reagents
5.2.2 Synthesis Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cell Based Assays Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cell Based Assays Market Size Forecast by Applications
6.2.1 Research & Academic Institutes
6.2.2 Pharma & Biotech Companies
6.2.3 CROs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Based Assays Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Based Assays Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cell Based Assays Analysis and Forecast
9.1 Introduction
9.2 North America Cell Based Assays Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cell Based Assays Market Size Forecast by Type
9.6.1 Kits and Reagents
9.6.2 Synthesis Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cell Based Assays Market Size Forecast by Applications
9.10.1 Research & Academic Institutes
9.10.2 Pharma & Biotech Companies
9.10.3 CROs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cell Based Assays Analysis and Forecast
10.1 Introduction
10.2 Europe Cell Based Assays Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cell Based Assays Market Size Forecast by Type
10.6.1 Kits and Reagents
10.6.2 Synthesis Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cell Based Assays Market Size Forecast by Applications
10.10.1 Research & Academic Institutes
10.10.2 Pharma & Biotech Companies
10.10.3 CROs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cell Based Assays Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cell Based Assays Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cell Based Assays Market Size Forecast by Type
11.6.1 Kits and Reagents
11.6.2 Synthesis Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cell Based Assays Market Size Forecast by Applications
11.10.1 Research & Academic Institutes
11.10.2 Pharma & Biotech Companies
11.10.3 CROs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cell Based Assays Analysis and Forecast
12.1 Introduction
12.2 Latin America Cell Based Assays Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cell Based Assays Market Size Forecast by Type
12.6.1 Kits and Reagents
12.6.2 Synthesis Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cell Based Assays Market Size Forecast by Applications
12.10.1 Research & Academic Institutes
12.10.2 Pharma & Biotech Companies
12.10.3 CROs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cell Based Assays Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cell Based Assays Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cell Based Assays Market Size Forecast by Type
13.6.1 Kits and Reagents
13.6.2 Synthesis Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cell Based Assays Market Size Forecast by Applications
13.10.1 Research & Academic Institutes
13.10.2 Pharma & Biotech Companies
13.10.3 CROs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Based Assays Market: Competitive Dashboard
14.2 Global Cell Based Assays Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Agilent
14.3.3 Merck KGaA
14.3.4 Qiagen
14.3.5 Bio-Rad
14.3.6 Promega
14.3.7 Funakoshi Co., Ltd.
14.3.8 BioVendor
14.3.9 Canopy Biosciences
14.3.10 Genecopoeia
14.3.11 GenoSensor
14.3.12 Takara Bio
14.3.13 Zymo Research
14.3.14 Biocat
14.3.15 LC Sciences
14.3.16 NanoString Technologies
14.3.17 Quanta BioSciences
14.3.18 Phalanx Biotech
14.3.19 FUJIFILM Wako Pure Chemical Corporation
